September, 2009Heparin: Change in Reference Standard
Audience: Pharmacists, physicians, hospital risk managers and consumers FDA notified healthcare professionals and patients of a change to heparin, effective October 1, 2009, which will include a new reference standard and test method used to…
Bacterial Infections Common Among H1N1 Flu Deaths, CDC Says
Most people who have died while infected with the H1N1 influenza virus also carried a type of bacterial infection that likely played a part in their death, a new federal government study has found.
Continue →Dementia Drug Aricept Linked to Increased Heart-Injury Hospitalizations
A commonly prescribed dementia drug puts patients at twice the risk of being hospitalized for a potentially life-threatening heart condition, Canadian researchers say.
Continue →Blood Thinner Heparin Was Intentionally Contaminated to Boost Company Profits, Lawsuit Claims
Makers of the blood-thinning drug heparin intentionally used a counterfeit active ingredient blamed for causing at least 100 deaths and hundreds of injuries to increase company profits, according to a lawsuit just filed by a California couple.
Continue →Infant Burned by Icy Hot Patch, New Lawsuit Claims
A West Virginia woman is suing the makers of the Icy Hot patch, claiming the pain remedy caused disfiguring burns and other injuries to an infant boy in her care.
Continue →Woman Blames Daughter’s Death on Risperdal Prescription
Use of the antipsychotic drug Risperdal caused an Illinois girl to develop sleep apnea, a condition that was not properly treated by doctors, causing the girl’s death, according to a new lawsuit.
Continue →Compact Tractors Recalled by John Deere Due to Injury Hazard
An incorrectly sized differential was installed in the tractor transaxle affecting the engagement of the differential lock and causing the tractor to turn to the left when braking. This causes the vehicle to veer left when the brake is applied, posing a risk of collision and injury to the operator and bystanders.
Continue →LexisNexis® Legal News Podcast for September 30, 2009
A federal judge preliminarily approves a $19.9 million settlement of a RESPA class action against J.P. Morgan Chase Bank, and, a Philadelphia jury finds a woman’s use of Prempro caused her breast cancer and she should receive more than $3.5 million. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
Toyota Plans Recall of 3.8 Million Vehicles Due to Defective Floor Mats
Toyota Motor Corp. said today it will soon announce its largest-ever U.S. safety recall, affecting nearly four million cars and trucks, due to reports of all-weather floor mats in the vehicles sliding out of place and trapping the accelerator pedal to the floor, forcing cars to speed out of control. The auto maker has issued an urgent safety warning for owners of eight vehicle models from about 20 model years to warn them of the risks of deadly accidents when …
Continue →Woman Blames Birth Control Pill Yaz/Yasmin for Deadly Blood Clot
A Texas woman is suing the makers of the birth control pills Yaz and Yasmin, accusing the products of causing a blood clot that resulted in the death of her unborn baby.
Continue →Recent Related Features
All Stories
facebook
rss
twitter